Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies.

Kim I, Lee J, Hong HJ, Jung ES, Ku YH, Jeong IK, Cho YM, So I, Park KS, Mook-Jung I.

J Alzheimers Dis. 2010;19(4):1371-6. doi: 10.3233/JAD-2010-1332.

PMID:
20061608
2.

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.

Abdullah L, Paris D, Luis C, Quadros A, Parrish J, Valdes L, Keegan AP, Mathura V, Crawford F, Mullan M.

Neurosci Lett. 2007 Nov 27;428(2-3):53-8. Epub 2007 Oct 2.

PMID:
17964720
3.

Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.

Sohn JH, So JO, Kim H, Nam EJ, Ha HJ, Kim YH, Mook-Jung I.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):800-4. Epub 2007 Jul 27.

PMID:
17678618
4.

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, Tanzi RE.

J Biol Chem. 2005 Apr 29;280(17):17458-63. Epub 2005 Feb 21.

5.

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.

Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, Zamrini EY, Schade RF.

Neurobiol Aging. 2004 Sep;25(8):1023-32.

PMID:
15212827
6.

Autoantibodies to amyloid-beta and Alzheimer's disease.

Hyman BT, Smith C, Buldyrev I, Whelan C, Brown H, Tang MX, Mayeux R.

Ann Neurol. 2001 Jun;49(6):808-10.

PMID:
11409436
7.

Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type.

Myagkova MA, Gavrilova SI, Lermontova NN, Kalyn YB, Selezneva ND, Zharikov GA, Kolykhalov IV, Abramenko TV, Serkova TP, Bachurin SO.

Bull Exp Biol Med. 2001 Feb;131(2):127-9.

PMID:
11391392
8.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
9.

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.

Du Y, Dodel R, Hampel H, Buerger K, Lin S, Eastwood B, Bales K, Gao F, Moeller HJ, Oertel W, Farlow M, Paul S.

Neurology. 2001 Sep 11;57(5):801-5.

PMID:
11552007
10.

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.

Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, Laughton K, Masters CL, Pertile K, Rembach A, Rimajova M, Rodrigues M, Rowe CC, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ward V, Martins RN, AIBL Research Group.

J Alzheimers Dis. 2010;20(4):1233-42. doi: 10.3233/JAD-2010-090249.

PMID:
20413897
11.

Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.

Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa IT, Przybylski M, Manea M, von Arnim CA.

PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.

12.

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P.

Curr Alzheimer Res. 2005 Dec;2(5):527-39.

PMID:
16375656
13.

Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects.

Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, Sassolas A, McCormick JB, Trannoy E.

Neurosci Lett. 2004 Jan 30;355(3):226-30.

PMID:
14732472
14.

No correlation between time-linked plasma and CSF Abeta levels.

Le Bastard N, Aerts L, Leurs J, Blomme W, De Deyn PP, Engelborghs S.

Neurochem Int. 2009 Dec;55(8):820-5. doi: 10.1016/j.neuint.2009.08.006. Epub 2009 Aug 18.

PMID:
19695299
15.

Measurement of anti-beta amyloid antibodies in human blood.

Szabo P, Mujalli DM, Rotondi ML, Sharma R, Weber A, Schwarz HP, Weksler ME, Relkin N.

J Neuroimmunol. 2010 Oct 8;227(1-2):167-74. doi: 10.1016/j.jneuroim.2010.06.010. Epub 2010 Jul 31.

PMID:
20638733
17.

Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.

Lopez LR, Hurley BL, Simpson DF, Matsuura E.

Ann N Y Acad Sci. 2005 Jun;1051:97-103.

PMID:
16126948
19.

Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.

Kojro E, Postina R.

J Alzheimers Dis. 2009;16(4):865-78. doi: 10.3233/JAD-2009-0998. Review.

PMID:
19387119
20.

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K.

Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19.

PMID:
18486992

Supplemental Content

Support Center